Vice President, Value and Market Access Strategy

Who We Are

Cogent Biosciences is a publicly traded biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis (SM), a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Top-line results from registration-directed trials in NonAdvanced SM, Advanced SM and GIST are expected in 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor. In addition, the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.

Our Team

https://cogent.culturehq.com

The Vice President, Value & Market Access Strategy is a critical role within Cogent Biosciences commercial organization.  Reporting to the SVP, Market Access, he/she works closely with a cross-functional group including Medical, Account Managers, Marketing, Compliance, Legal, Commercial Operations and external stakeholders to develop pricing strategies, HEOR & budget impact models (value models) to ensure broad patient access. He/She is responsible for the development and execution of HEOR models and payer marketing strategies to secure, maintain and drive optimal access for Cogent’s product portfolio. The role is also responsible for strategic pricing and contracting for the Cogent portfolio. The candidate must be a strategic thinker with a proven ability to drive cross-functional execution both internally and externally.

• Build strategies and optimize portfolio value through customer insight, evidence generation, value communication, and govern a disciplined pricing framework for executive decision-making
• Collaborates with cross-functional partners (Brand Marketing, Account Directors, Medical Affairs, and other key internal stakeholders) to develop comprehensive strategies and tactics that align to the brand strategy
• Assist in development of pricing strategies with a focus on value and health economics
• Develop pricing & contracting strategies across all institutional and provider customer channels, and contribute to development of gross-to-net financial forecasts
• In partnership with Medical develop the value proposition including market research and development of tools and resources that effectively communicate the value of Cogent’s products to payers and key customers
• This individual will monitor the changing payer landscape mergers and acquisitions, benefit design trends, strategic account trends, medical loss ratios, quality metrics, and the evolution of the impact of policy changes
• Serve as key member of Market Access leadership team with continuous input into team capabilities, resourcing, and strategic objectives
• Development of strategy programs to support education of physicians/hospitals/practices/patients on matters related to pricing, HEOR, reimbursement and market access
• Partners with therapeutic area marketing lead to develop and execute HEOR strategies & patient access
• Identify opportunities for solutions to provide improved patient access, i.e., value-based contracts, new partnering models, contracting etc
• Partner with Legal and Compliance to ensure that all programs and tools are consistent with the latest laws, guidance, and corporate policies
• Provide proactive market feedback to Market Access and cross functional teams on business trends, competitive updates, industry issues and opportunities

• BA/BS degree required. An advanced degree in Finance, Health Economics, or a similar discipline is preferred
• Minimum of 12 years’ experience in pharmaceutical, biotech or related industry
• Prefer minimum of 8 years of experience in the following areas: Pricing, HEOR development, Managed Care Channel Marketing and or Payer Marketing
• Strong understanding of HEOR modelling, value creating, orphan drug pricing and payer processes
• In-depth knowledge of and hands-on experience in health outcomes, health economics and pricing
• Knowledge of the business models, influence/impact, and decision drivers of U.S. commercial and government payers
• Understanding of reimbursement methodologies utilized by commercial and government payers under pharmacy and medical benefits
• Proven ability of successfully managing complexity, solving problems, and building strong relationships

Our Locations

Waltham, MA: Our Boston office includes an open office layout that has recently undergone a makeover designed for collaboration and giving our employees the best work place possible. Free access is provided for both on-site parking and gym facilities in the building.

Boulder, CO: We have just moved into our new state-of-the art Research Facility in the fast-growing biopharmaceutical hub in the greater Denver/Boulder corridor.  Our CEO is based full-time in this location and we are proud to call this the home of Cogent’s discovery research organization.

Our Offer To You

To attract the very best talent, we offer a generous benefits package that includes competitive pay, performance-based bonus, stock options, insurance coverage (health, dental, life, and disability), competitive time-off, a 401(k) plan, and commuter/parking benefits.

We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.

Salary : $304,074 - $357,180